Abstract
In the title compound, C13H10BrNOS2, the rhodanine (systematic name: 2-sulfanylidene-1,3-thiazolidin-4-one) and the 3-bromobenzylidene ring systems are inclined slightly, forming a dihedral angle of 5.86 (12)°. The rhodanine moiety is linked to an allyl group at the N atom and to the 3-bromobenzylidene ring system. The allyl group, C=C—C, is nearly perpendicular to the mean plane through the rhodanine ring, maling a dihedral angle of 87.2 (5)°. In the crystal, molecules are linked by pairs of C—H⋯O hydrogen bonds, forming inversion dimers with an R 2 2(10) ring motif.
Keywords: crystal structure, rhodanine, hydrogen bonding
Related literature
For pharmacological and biological activities of rhodanine-based molecules, see: Tomasić & Masic (2009 ▸); Sortino et al. (2007 ▸); Kesel (2003 ▸); Capan et al. (1996 ▸); Momose et al. (1991 ▸); Kawakami et al. (1998 ▸); Insuasty et al. (2010 ▸). For the crystal structure of a related compound, see: El Ajlaoui et al. (2015 ▸).
Experimental
Crystal data
C13H10BrNOS2
M r = 340.25
Triclinic,
a = 5.4044 (6) Å
b = 11.2306 (13) Å
c = 11.7966 (13) Å
α = 80.100 (5)°
β = 84.912 (6)°
γ = 76.732 (6)°
V = 685.60 (13) Å3
Z = 2
Mo Kα radiation
μ = 3.29 mm−1
T = 296 K
0.31 × 0.27 × 0.21 mm
Data collection
Bruker X8 APEX diffractometer
Absorption correction: multi-scan (SADABS; Bruker, 2009 ▸) T min = 0.479, T max = 0.746
25482 measured reflections
4181 independent reflections
2895 reflections with I > 2σ(I)
R int = 0.044
Refinement
R[F 2 > 2σ(F 2)] = 0.039
wR(F 2) = 0.098
S = 1.01
4181 reflections
163 parameters
H-atom parameters constrained
Δρmax = 0.95 e Å−3
Δρmin = −0.71 e Å−3
Data collection: APEX2 (Bruker, 2009 ▸); cell refinement: SAINT (Bruker, 2009 ▸); data reduction: SAINT; program(s) used to solve structure: SHELXS2014 (Sheldrick, 2008 ▸); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015 ▸); molecular graphics: ORTEPIII (Burnett & Johnson, 1996 ▸), ORTEP-3 for Windows (Farrugia, 2012 ▸) and PLATON (Spek, 2009 ▸); software used to prepare material for publication: publCIF (Westrip, 2010 ▸).
Supplementary Material
Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015022884/su5249sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015022884/su5249Isup2.hkl
Supporting information file. DOI: 10.1107/S2056989015022884/su5249Isup3.cml
. DOI: 10.1107/S2056989015022884/su5249fig1.tif
A view of the molecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level.
a . DOI: 10.1107/S2056989015022884/su5249fig2.tif
A view along the a axis of the crystal packing of the title compound, showing the hydrogen bonds as dashed lines (see Table 1).
CCDC reference: 1439611
Additional supporting information: crystallographic information; 3D view; checkCIF report
Table 1. Hydrogen-bond geometry (Å, °).
| D—H⋯A | D—H | H⋯A | D⋯A | D—H⋯A |
|---|---|---|---|---|
| C7—H7⋯O1i | 0.93 | 2.42 | 3.310 (3) | 159 |
Symmetry code: (i)
.
Acknowledgments
The authors thank the Unit of Support for Technical and Scientific Research (UATRS, CNRST) for the X-ray measurements and the University Sultan Moulay Slimane, Beni-Mellal, Morocco, for financial support.
supplementary crystallographic information
S1. Structural commentary
Rhodanine is an attractive scaffold unit because of its prestigious position in medicinal chemistry as it is responsible for numerous pharmacological and biological activities (Tomasic & Masic, 2009), e.g., antimicrobial, antiviral, anticonvulsant, antidiabetic and antitumor activities (Sortino et al., 2007; Kesel, 2003; Capan et al., 1996; Momose et al., 1991; Kawakami et al., 1998; Insuasty et al. 2010). The unusual biological activity displayed by many rhodanine-based molecules have made them attractive synthetic targets.
The title compound, Fig. 1, is build up from a rhodanine ring (S1/N/1 C8–C10) linked to an allyl group (C11–C13) at the nitrogen atom and to a 3-bromobenzylidene ring system (C1—C6). The mean plane through the rhodanine ring is almost perpendicular to the allyl group (C11—C13) with a dihedral angle of 87.2 (5) °, and makes a dihedral angle of 5.86 (12)° with the 3-bromobenzylidene ring. A very similar arrangement has been observed in the crystal structure of (Z)-3-allyl-5-(4-methyl-benzylidene)-2-thioxothiazolidin-4-one, but with disorder in the allyl group (El Ajlaoui et al., 2015).
In the crystal, molecules are linked by a pair of C—H···O hydrogen bonds forming inversion dimers with an R22(10) ring motif (Table 1 and Fig. 2).
S2. Synthesis and crystallization
To a solution of 3-allylrhodanine (1.15 mmol, 0.2 g) in 10 ml of THF, (3-bromobenzylidene)-4-methyl-5-oxopyrazolidin-2-ium-1-ide (1.38 mmol) was added and the mixture refluxed for 8 h, monitored by TLC. On completion of the reaction, with a yellow spot (TLC Rf = 0.3, using hexane/ethyl acetate 1:9) generated cleanly, the solvent was evaporated in vacuo. The crude product was purified on silica gel using hexane:ethyl acetate (1:9) as eluent. The title compound was recrystallized from ethanol giving colourless block-like crystals (yield: 76%; m.p. 390 K).
S3. Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2. H atoms were located in a difference Fourier map and treated as riding: C–H = 0.93–0.97 Å with Uiso(H) = 1.2Ueq(C). Two reflections, (0 1 0) and (0 0 1), affected by the beam-stop were removed during the final cycles of refinement.
Figures
Fig. 1.

A view of the molecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level.
Fig. 2.

A view along the a axis of the crystal packing of the title compound, showing the hydrogen bonds as dashed lines (see Table 1).
Crystal data
| C13H10BrNOS2 | F(000) = 340 |
| Mr = 340.25 | Dx = 1.648 Mg m−3 |
| Triclinic, P1 | Melting point: 390 K |
| a = 5.4044 (6) Å | Mo Kα radiation, λ = 0.71073 Å |
| b = 11.2306 (13) Å | Cell parameters from 4181 reflections |
| c = 11.7966 (13) Å | θ = 2.8–30.5° |
| α = 80.100 (5)° | µ = 3.29 mm−1 |
| β = 84.912 (6)° | T = 296 K |
| γ = 76.732 (6)° | Block, colourless |
| V = 685.60 (13) Å3 | 0.31 × 0.27 × 0.21 mm |
| Z = 2 |
Data collection
| Bruker X8 APEX diffractometer | 4181 independent reflections |
| Radiation source: fine-focus sealed tube | 2895 reflections with I > 2σ(I) |
| Graphite monochromator | Rint = 0.044 |
| φ and ω scans | θmax = 30.5°, θmin = 2.8° |
| Absorption correction: multi-scan (SADABS; Bruker, 2009) | h = −7→7 |
| Tmin = 0.479, Tmax = 0.746 | k = −16→16 |
| 25482 measured reflections | l = −16→16 |
Refinement
| Refinement on F2 | 0 restraints |
| Least-squares matrix: full | Hydrogen site location: inferred from neighbouring sites |
| R[F2 > 2σ(F2)] = 0.039 | H-atom parameters constrained |
| wR(F2) = 0.098 | w = 1/[σ2(Fo2) + (0.0356P)2 + 0.492P] where P = (Fo2 + 2Fc2)/3 |
| S = 1.01 | (Δ/σ)max = 0.001 |
| 4181 reflections | Δρmax = 0.95 e Å−3 |
| 163 parameters | Δρmin = −0.71 e Å−3 |
Special details
| Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
| x | y | z | Uiso*/Ueq | ||
| C1 | 0.7585 (5) | 0.8474 (2) | 0.6704 (2) | 0.0449 (5) | |
| C2 | 0.7277 (6) | 0.8621 (3) | 0.5535 (2) | 0.0578 (7) | |
| H2 | 0.7974 | 0.9201 | 0.5025 | 0.069* | |
| C3 | 0.5914 (6) | 0.7891 (3) | 0.5138 (2) | 0.0625 (8) | |
| H3 | 0.5704 | 0.7977 | 0.4352 | 0.075* | |
| C4 | 0.4861 (5) | 0.7039 (3) | 0.5885 (2) | 0.0516 (6) | |
| H4 | 0.3934 | 0.6562 | 0.5601 | 0.062* | |
| C5 | 0.5173 (4) | 0.6882 (2) | 0.70721 (19) | 0.0379 (5) | |
| C6 | 0.6565 (4) | 0.7623 (2) | 0.7469 (2) | 0.0392 (5) | |
| H6 | 0.6799 | 0.7540 | 0.8253 | 0.047* | |
| C7 | 0.4177 (4) | 0.5987 (2) | 0.79133 (19) | 0.0386 (5) | |
| H7 | 0.4638 | 0.5940 | 0.8663 | 0.046* | |
| C8 | 0.2693 (4) | 0.5212 (2) | 0.77866 (18) | 0.0358 (4) | |
| C9 | 0.1983 (4) | 0.4349 (2) | 0.87829 (19) | 0.0402 (5) | |
| C10 | −0.0140 (4) | 0.3884 (2) | 0.7315 (2) | 0.0385 (5) | |
| C11 | −0.0559 (5) | 0.2749 (3) | 0.9303 (2) | 0.0538 (7) | |
| H11A | −0.2218 | 0.2691 | 0.9094 | 0.065* | |
| H11B | −0.0769 | 0.3018 | 1.0051 | 0.065* | |
| C12 | 0.1173 (8) | 0.1500 (3) | 0.9393 (3) | 0.0717 (9) | |
| H12 | 0.0739 | 0.0898 | 0.9972 | 0.086* | |
| C13 | 0.3193 (8) | 0.1155 (3) | 0.8769 (3) | 0.0845 (11) | |
| H13A | 0.3724 | 0.1716 | 0.8176 | 0.101* | |
| H13B | 0.4125 | 0.0343 | 0.8909 | 0.101* | |
| N1 | 0.0372 (4) | 0.36716 (18) | 0.84606 (16) | 0.0398 (4) | |
| O1 | 0.2673 (4) | 0.42021 (19) | 0.97577 (14) | 0.0579 (5) | |
| S1 | 0.13666 (12) | 0.50102 (6) | 0.65523 (5) | 0.04169 (14) | |
| S2 | −0.18899 (14) | 0.31940 (7) | 0.67061 (6) | 0.05491 (18) | |
| Br1 | 0.94248 (6) | 0.94874 (3) | 0.72543 (3) | 0.06670 (13) |
Atomic displacement parameters (Å2)
| U11 | U22 | U33 | U12 | U13 | U23 | |
| C1 | 0.0478 (14) | 0.0440 (13) | 0.0461 (13) | −0.0140 (11) | −0.0009 (10) | −0.0110 (10) |
| C2 | 0.0697 (18) | 0.0600 (17) | 0.0465 (14) | −0.0269 (14) | 0.0026 (13) | −0.0013 (12) |
| C3 | 0.080 (2) | 0.079 (2) | 0.0341 (13) | −0.0327 (17) | −0.0068 (13) | −0.0022 (13) |
| C4 | 0.0625 (16) | 0.0627 (16) | 0.0376 (12) | −0.0268 (13) | −0.0082 (11) | −0.0086 (11) |
| C5 | 0.0402 (12) | 0.0407 (12) | 0.0345 (11) | −0.0097 (9) | −0.0058 (9) | −0.0077 (9) |
| C6 | 0.0424 (12) | 0.0420 (12) | 0.0356 (11) | −0.0106 (10) | −0.0030 (9) | −0.0105 (9) |
| C7 | 0.0418 (12) | 0.0450 (12) | 0.0319 (10) | −0.0102 (10) | −0.0087 (9) | −0.0097 (9) |
| C8 | 0.0381 (11) | 0.0397 (11) | 0.0315 (10) | −0.0072 (9) | −0.0077 (8) | −0.0093 (9) |
| C9 | 0.0434 (12) | 0.0455 (12) | 0.0359 (11) | −0.0142 (10) | −0.0071 (9) | −0.0091 (9) |
| C10 | 0.0346 (11) | 0.0436 (12) | 0.0403 (12) | −0.0059 (9) | −0.0075 (9) | −0.0152 (9) |
| C11 | 0.0588 (16) | 0.0713 (18) | 0.0417 (13) | −0.0359 (14) | 0.0026 (11) | −0.0107 (12) |
| C12 | 0.106 (3) | 0.0573 (18) | 0.0569 (18) | −0.0387 (18) | −0.0014 (18) | 0.0050 (14) |
| C13 | 0.098 (3) | 0.060 (2) | 0.082 (3) | −0.0004 (19) | −0.008 (2) | 0.0036 (18) |
| N1 | 0.0432 (10) | 0.0464 (11) | 0.0345 (9) | −0.0159 (9) | −0.0060 (8) | −0.0085 (8) |
| O1 | 0.0756 (13) | 0.0754 (13) | 0.0335 (9) | −0.0392 (11) | −0.0177 (8) | 0.0004 (8) |
| S1 | 0.0471 (3) | 0.0495 (3) | 0.0328 (3) | −0.0148 (3) | −0.0131 (2) | −0.0066 (2) |
| S2 | 0.0547 (4) | 0.0703 (4) | 0.0517 (4) | −0.0268 (3) | −0.0135 (3) | −0.0194 (3) |
| Br1 | 0.0796 (2) | 0.0688 (2) | 0.0663 (2) | −0.04359 (17) | 0.00513 (15) | −0.01814 (15) |
Geometric parameters (Å, º)
| C1—C6 | 1.374 (3) | C8—S1 | 1.749 (2) |
| C1—C2 | 1.381 (4) | C9—O1 | 1.213 (3) |
| C1—Br1 | 1.896 (2) | C9—N1 | 1.394 (3) |
| C2—C3 | 1.380 (4) | C10—N1 | 1.372 (3) |
| C2—H2 | 0.9300 | C10—S2 | 1.631 (2) |
| C3—C4 | 1.374 (4) | C10—S1 | 1.739 (2) |
| C3—H3 | 0.9300 | C11—N1 | 1.453 (3) |
| C4—C5 | 1.401 (3) | C11—C12 | 1.489 (5) |
| C4—H4 | 0.9300 | C11—H11A | 0.9700 |
| C5—C6 | 1.401 (3) | C11—H11B | 0.9700 |
| C5—C7 | 1.447 (3) | C12—C13 | 1.283 (5) |
| C6—H6 | 0.9300 | C12—H12 | 0.9300 |
| C7—C8 | 1.345 (3) | C13—H13A | 0.9300 |
| C7—H7 | 0.9300 | C13—H13B | 0.9300 |
| C8—C9 | 1.472 (3) | ||
| C6—C1—C2 | 121.4 (2) | C9—C8—S1 | 109.66 (16) |
| C6—C1—Br1 | 119.79 (18) | O1—C9—N1 | 122.5 (2) |
| C2—C1—Br1 | 118.8 (2) | O1—C9—C8 | 127.0 (2) |
| C3—C2—C1 | 118.7 (2) | N1—C9—C8 | 110.44 (18) |
| C3—C2—H2 | 120.7 | N1—C10—S2 | 126.32 (19) |
| C1—C2—H2 | 120.7 | N1—C10—S1 | 110.91 (16) |
| C4—C3—C2 | 121.1 (3) | S2—C10—S1 | 122.77 (14) |
| C4—C3—H3 | 119.5 | N1—C11—C12 | 113.0 (2) |
| C2—C3—H3 | 119.5 | N1—C11—H11A | 109.0 |
| C3—C4—C5 | 120.6 (2) | C12—C11—H11A | 109.0 |
| C3—C4—H4 | 119.7 | N1—C11—H11B | 109.0 |
| C5—C4—H4 | 119.7 | C12—C11—H11B | 109.0 |
| C6—C5—C4 | 118.1 (2) | H11A—C11—H11B | 107.8 |
| C6—C5—C7 | 117.89 (19) | C13—C12—C11 | 127.9 (3) |
| C4—C5—C7 | 124.0 (2) | C13—C12—H12 | 116.1 |
| C1—C6—C5 | 120.2 (2) | C11—C12—H12 | 116.1 |
| C1—C6—H6 | 119.9 | C12—C13—H13A | 120.0 |
| C5—C6—H6 | 119.9 | C12—C13—H13B | 120.0 |
| C8—C7—C5 | 130.5 (2) | H13A—C13—H13B | 120.0 |
| C8—C7—H7 | 114.8 | C10—N1—C9 | 116.30 (19) |
| C5—C7—H7 | 114.8 | C10—N1—C11 | 123.3 (2) |
| C7—C8—C9 | 120.37 (19) | C9—N1—C11 | 120.27 (19) |
| C7—C8—S1 | 129.97 (18) | C10—S1—C8 | 92.61 (11) |
Hydrogen-bond geometry (Å, º)
| D—H···A | D—H | H···A | D···A | D—H···A |
| C7—H7···O1i | 0.93 | 2.42 | 3.310 (3) | 159 |
Symmetry code: (i) −x+1, −y+1, −z+2.
Footnotes
Supporting information for this paper is available from the IUCr electronic archives (Reference: SU5249).
References
- Bruker (2009). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
- Burnett, M. N. & Johnson, C. K. (1996). ORTEPIII. Report ORNL-6895. Oak Ridge National Laboratory, Tennessee, USA.
- Capan, G., Ulusoy, N., Ergenç, N., Cevdet Ekinci, A. & Vidin, A. (1996). Farmaco, 51, 729–732. [PubMed]
- El Ajlaoui, R., Rakib, E. M., Chigr, M., Saadi, M. & El Ammari, L. (2015). Acta Cryst. E71, o906–o907. [DOI] [PMC free article] [PubMed]
- Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.
- Insuasty, B., Gutie’rrez, A., Quiroga, J., Abonia, R., Nogueras, M., Cobo, J., Svetaz, L., Raimondi, M. & Zacchino, S. (2010). Arch. Pharm. 343, 48–53. [DOI] [PubMed]
- Kawakami, M., Koya, K., Ukai, T., Tatsuta, N., Ikegawa, A., Ogawa, K., Shishido, T. & Chen, L. B. (1998). J. Med. Chem. 41, 130–142. [DOI] [PubMed]
- Kesel, A. J. (2003). Biochem. Biophys. Res. Commun. 300, 793–799. [DOI] [PubMed]
- Momose, Y., Meguro, K., Ikeda, H., Hatanaka, C., Oi, S. & Sohda, T. (1991). Chem. Pharm. Bull. 39, 1440–1445. [DOI] [PubMed]
- Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
- Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
- Sortino, M., Delgado, P., Juárez, S. F., Quiroga, J., Abonía, R., Insuasty, B., Nogueras, M., Rodero, L., Garibotto, F. M., Enriz, R. D. & Zacchino, S. A. (2007). Bioorg. Med. Chem. 15, 484–494. [DOI] [PubMed]
- Spek, A. L. (2009). Acta Cryst. D65, 148–155. [DOI] [PMC free article] [PubMed]
- Tomasić, T. & Masic, L. P. (2009). Curr. Med. Chem. 16, 1596–1629. [DOI] [PubMed]
- Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015022884/su5249sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015022884/su5249Isup2.hkl
Supporting information file. DOI: 10.1107/S2056989015022884/su5249Isup3.cml
. DOI: 10.1107/S2056989015022884/su5249fig1.tif
A view of the molecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level.
a . DOI: 10.1107/S2056989015022884/su5249fig2.tif
A view along the a axis of the crystal packing of the title compound, showing the hydrogen bonds as dashed lines (see Table 1).
CCDC reference: 1439611
Additional supporting information: crystallographic information; 3D view; checkCIF report
